AMPLIGEN
Live / Registered — Registered and renewed (as of 21 Dec 2018)
What this means for you
Registered since 06 Dec 1988. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 06 Dec 2018).
Record
- Serial number
- 73617687
- Registration number
- 1515099
- Mark type
- Word mark
- Filed
- 02 Sept 1986
- Published for opposition
- 13 Sept 1988
- Registered
- 06 Dec 1988
- Next maintenance due
- 06 Dec 2018
- Attorney of record
- DONNA J. BUNTON
Goods and services
- Class 005 — Pharmaceuticals: INTRAVENOUS SOLUTION FOR USE IN THE TREATMENT OF VIRAL INFECTIONS
Owner
- AIM IMMUNOTECH INC., OCALA, FL, US
- HEMISPHERX BIOPHARMA, INC., Orlandon, FL, US
- HEM PHARMACEUTICALS CORP., PHILADELPHIA, PA, US
- HEM RESEARCH INCORPORATED, ROCKVILLE, MD, US
- HEM RESEARCH INCORPORATED, ROCKVILLE, MD, US
- HEM RESEARCH INCORPORATED, ROCKVILLE, MD, US
Prosecution history
- 09 Oct 2019 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 21 Dec 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 21 Dec 2018 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 21 Dec 2018 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 18 Dec 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 05 Dec 2018 — TEAS SECTION 8 & 9 RECEIVED
- 06 Mar 2009 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 06 Mar 2009 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 04 Mar 2009 — ASSIGNED TO PARALEGAL
- 20 Feb 2009 — REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
- 20 Feb 2009 — PAPER RECEIVED
- 17 Dec 2008 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 06 Aug 2008 — CASE FILE IN TICRS
- 01 Aug 1995 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 05 Dec 1994 — REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED